Page last updated: 2024-10-29

iopromide and Polycystic Kidney Diseases

iopromide has been researched along with Polycystic Kidney Diseases in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joo, I1
Kim, SH1
Cho, JY1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Correlation Between Seminal Vesicle Size and Duration of Sexual Abstinence[NCT05192252]250 participants (Anticipated)Observational2021-11-02Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for iopromide and Polycystic Kidney Diseases

ArticleYear
A comparison of seminal vesicle size on CT between autosomal dominant polycystic kidney disease (ADPKD) patients and normal subjects.
    Acta radiologica (Stockholm, Sweden : 1987), 2010, Volume: 51, Issue:5

    Topics: Adult; Aged; Case-Control Studies; Contrast Media; Humans; Iohexol; Male; Middle Aged; Polycystic Ki

2010